Horrell Capital Management, Inc. Cara Therapeutics, Inc. Transaction History

Horrell Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 23, 2019	SELL	$14.41 - $19.64 $2,882 - $3,928	-200 Reduced 50.0%	200 $4,000
Q1 2018 Apr 11, 2018	BUY	$11.77 - $16.08 $2,354 - $3,215	200 Added 100.0%	400 $5,000
Q3 2017 Oct 12, 2017	BUY	$12.6 - $16.34 $2,520 - $3,268	200	200 $3,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Horrell Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Horrell Capital Management, Inc. with notifications on news.